Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Oncogene|January 12, 2019
Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targetingHanna Karvonen, Robert Perttilä, Wilhelmiina Niininen, et al.
Translational Oncology|February 2, 2021
STRN-ALK rearranged pediatric malignant peritoneal mesothelioma - Functional testing of 527 cancer drugs in patient-derived cancer cellsAstrid Murumägi, Daniela Ungureanu, Mariliina Arjama, et al.
Blood|July 12, 2003
PIAS proteins promote SUMO-1 conjugation to STAT1Daniela Ungureanu, Sari Vanhatupa, Noora Kotaja, et al.
Biochimica Et Biophysica Acta|August 10, 2014
The JH2 domain and SH2-JH2 linker regulate JAK2 activity: A detailed kinetic analysis of wild type and V617F mutant kinase domainsArturo Sanz Sanz, Yashavanthi Niranjan, Henrik Hammarén, et al.
Romanian Journal of Anaesthesia and Intensive Care|September 16, 2017
The impact of donor liver graft quality on postoperative outcome in liver transplant recipients. A single centre experienceDana Tomescu, Mihai Popescu, Lavinia Jipa, et al.
Analytical Biochemistry|July 30, 2013
Analysis of steady-state Förster resonance energy transfer data by avoiding pitfalls: interaction of JAK2 tyrosine kinase with N-methylanthraniloyl nucleotidesYashavanthi Niranjan, Daniela Ungureanu, Henrik Hammarén, et al.
Cell Death Discovery|November 6, 2025
Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilitiesFrida Rantanen, Astrid Murumägi, Mariliina Arjama, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Identification and Characterization of JAK2 Pseudokinase Domain Small Molecule BindersDavid E Puleo, Kaury Kucera, Henrik M Hammarén, et al.
Nature Structural & Molecular Biology|June 12, 2014
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinaseYibing Shan, Kavitha Gnanasambandan, Daniela Ungureanu, et al.
Molecular Therapy. Oncology|December 5, 2024
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responsesEmilia Piki, Alice Dini, Frida Rantanen, et al.
Pageof 5